Prev:Bone marrow-derived Ly6C− macrophages promote ischemia-induced chronic kidney disease(A01020-5.72)
Next:Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways(A01020-4.1)